» Articles » PMID: 39910334

Peroxisome Proliferator-activated Receptor Alpha is an Essential Factor in Enhanced Macrophage Immune Function Induced by Angiotensin-converting Enzyme

Abstract

Increased expression of angiotensin-converting enzyme (ACE) by myeloid lineage cells strongly increases the immune activity of these cells, as observed in ACE10/10 mice, which exhibit a marked increase in antitumor and antibactericidal immunity. We report that peroxisome proliferator-activated receptor alpha (PPARα), a transcription factor that regulates genes critical for lipid metabolism, is a key molecule in the enhanced macrophage function induced by ACE. Here, we used a Cre-LoxP approach with LysM-Cre to create a modified ACE10/10 mouse line in which macrophages continue to generate abundant ACE but in which monocyte and macrophage PPARα expression is selectively suppressed. These mice, termed A10-PPARα-Cre, have significantly increased growth of B16-F10 tumors compared with ACE10/10 mice with Cre expression. PPARα depletion impaired cytokine production and antigen-presenting activity in ACE-expressing macrophages, resulting in reduced tumor antigen-specific CD8 T-cell generation. Additionally, the elevated bactericidal resistance typical of ACE10/10 mice was significantly reduced in A10-PPARα-Cre mice, such that these mice resembled WT mice in their resistance to methicillin-resistant Staphylococcus aureus (MRSA) infection. THP-1 cells expressing increased ACE (termed THP-1-ACE) constitute a human macrophage model with increased PPARα that shows enhanced cytotoxicity against tumor cells and better phagocytosis and killing of MRSA. RNA silencing of PPARα in THP-1-ACE cells reduced both tumor cell death and bacterial phagocytosis and clearance. In contrast, the in vivo administration of pemafibrate, a specific agonist of PPARα, to WT and A10-PPARα-Cre mice reduced B16-F10 tumor growth by 24.5% and 25.8%, respectively, but pemafibrate reduced tumors by 57.8% in ACE10/10 mice. With pemafibrate, the number of antitumor CD8 T cells was significantly lower in A10-PPARα-Cre mice than in ACE10/10 mice. We conclude that PPARα is important in the immune system of myeloid cells, including wild-type cells, and that its increased expression by ACE-expressing macrophages in ACE10/10 mice is indispensable for ACE-dependent functional upregulation of macrophages in both mice and human cells.

Citing Articles

Fueling defense: PPARα enhances macrophage inflammatory responses.

Hoeksema M Cell Mol Immunol. 2025; .

PMID: 40069341 DOI: 10.1038/s41423-025-01265-y.

References
1.
Shen X, Billet S, Lin C, Okwan-Duodu D, Chen X, Lukacher A . The carboxypeptidase ACE shapes the MHC class I peptide repertoire. Nat Immunol. 2011; 12(11):1078-85. PMC: 3197883. DOI: 10.1038/ni.2107. View

2.
Moore K, Rosen E, Fitzgerald M, RANDOW F, Andersson L, Altshuler D . The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat Med. 2001; 7(1):41-7. DOI: 10.1038/83328. View

3.
Russell D, Huang L, VanderVen B . Immunometabolism at the interface between macrophages and pathogens. Nat Rev Immunol. 2019; 19(5):291-304. PMC: 7032560. DOI: 10.1038/s41577-019-0124-9. View

4.
Sengupta S, Peterson T, Laplante M, Oh S, Sabatini D . mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature. 2010; 468(7327):1100-4. DOI: 10.1038/nature09584. View

5.
Peng Z, Saito S . Creatine supplementation enhances anti-tumor immunity by promoting adenosine triphosphate production in macrophages. Front Immunol. 2023; 14:1176956. PMC: 10471797. DOI: 10.3389/fimmu.2023.1176956. View